{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:29:11Z","timestamp":1790072951726,"version":"4.0.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The objective of this study was to apply a machine learning method to evaluate the risk factors associated with serious adverse events (SAEs) and predict the occurrence of SAEs in cancer inpatients using antineoplastic drugs. A retrospective review of the medical records of 499 patients diagnosed with cancer admitted between January 1 and December 31, 2017, was performed. First, the Global Trigger Tool (GTT) was used to actively monitor adverse drug events (ADEs) and SAEs caused by antineoplastic drugs and take the number of positive triggers as an intermediate variable. Subsequently, risk factors with statistical significance were selected by univariate analysis and least absolute shrinkage and selection operator (LASSO) analysis. Finally, using the risk factors after the LASSO analysis as covariates, a nomogram based on a logistic model, extreme gradient boosting (XGBoost), categorical boosting (CatBoost), adaptive boosting (AdaBoost), light-gradient-boosting machine (LightGBM), random forest (RF), gradient-boosting decision tree (GBDT), decision tree (DT), and ensemble model based on seven algorithms were used to establish the prediction models. A series of indicators such as the area under the ROC curve (AUROC) and the area under the PR curve (AUPR) was used to evaluate the model performance. A total of 94 SAE patients were identified in our samples. Risk factors of SAEs were the number of triggers, length of stay, age, number of combined drugs, ADEs occurred in previous chemotherapy, and sex. In the test cohort, a nomogram based on the logistic model owns the AUROC of 0.799 and owns the AUPR of 0.527. The GBDT has the best predicting abilities (AUROC = 0.832 and AUPR = 0.557) among the eight machine learning models and was better than the nomogram and was chosen to establish the prediction webpage. This study provides a novel method to accurately predict SAE occurrence in cancer inpatients.<\/jats:p>","DOI":"10.3389\/fphar.2022.896104","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T06:01:40Z","timestamp":1656482500000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning"],"prefix":"10.3389","volume":"13","author":[{"given":"Ni","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Qin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Lai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Tao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1002\/hsr2.160","article-title":"Describing Adverse Events in Swiss Hospitalized Oncology Patients Using the Global Trigger Tool","volume":"3","author":"Anne","year":"2020","journal-title":"Health Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention","volume":"274","author":"Bates","year":"1995","journal-title":"J. Am. Med. Assoc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","article-title":"How Important Are Gender Differences in Pharmacokinetics?","volume":"41","author":"Bernd","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21147\/j.issn.1000-9604.2017.03.11","article-title":"Expenditure of Hospital Care on Cancer in China, from 2011 to 2015","volume":"29","author":"Cai","year":"2017","journal-title":"Chin. J. Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1080\/0284186X.2017.1309063","article-title":"Adverse Events in Hospitalised Cancer Patients: a Comparison to a General Hospital Population","volume":"56","author":"Christin","year":"2017","journal-title":"Acta Oncol. Stockh. Swed."},{"key":"B6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/phar.1287","article-title":"Risk Factors for Hospital Admissions Associated with Adverse Drug Events","volume":"33","author":"Chuenjid","year":"2013","journal-title":"Pharmacotherapy."},{"key":"B7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1377\/hlthaff.2011.0190","article-title":"'Global Trigger Tool' Shows that Adverse Events in Hospitals May Be Ten Times Greater Than Previously Measured","volume":"30","author":"Classen","year":"2011","journal-title":"Health Aff. (Millwood)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.36660\/abc.20200596","article-title":"Machine Learning in Medicine: Review and Applicability","volume":"118","author":"de Mattos","year":"2022","journal-title":"Arq. Bras. Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10111-014-0302-2","article-title":"Use of the Global Trigger Tool in Patient Safety Improvement Efforts: Nordic Experiences","volume":"17","author":"Doupi","year":"2015","journal-title":"Cogn. Tech. Work"},{"key":"B10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000485078","article-title":"Risk Factors for Chemotherapy-Related Toxicity and Adverse Events in Elderly Thai Cancer Patients: A Prospective Study","volume":"94","author":"Ekkamol","year":"2018","journal-title":"Oncology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)32519-8","article-title":"Machine Learning-Based Prediction of Adverse Events Following an Acute Coronary Syndrome (PRAISE): a Modelling Study of Pooled Datasets","volume":"397","author":"Fabrizio","year":"2021","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.procs.2020.08.017","article-title":"Ppner. Multidimensional Decision Tree Splits to Improve Interpretability","volume":"176","author":"H\u00f6ppner","year":"2020","journal-title":"Procedia Comput. Sci."},{"key":"B13","first-page":"73","article-title":"Medication-related Adverse Outcomes and Contributing Factors Among Hospital Patients : an Analysis Using Hospitals Incident Reports, the Global Trigger Tool Method, and Observations with Record Reviews[J]","volume":"9","author":"H\u00e4rk\u00e4nen","year":"2014","journal-title":"J. Intern. Med. India"},{"key":"B14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/intqhc\/mzw115","article-title":"The Application of the Global Trigger Tool: a Systematic Review","volume":"28","author":"Hibbert","year":"2016","journal-title":"Int. J. Qual. Health Care"},{"key":"B15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Hyuna","year":"2021","journal-title":"A Cancer J. Clin."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1681\/ASN.2019070745","article-title":"A Time-Updated, Parsimonious Model to Predict AKI in Hospitalized Children","volume":"31","author":"Ibrahim","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/gerona\/glr118","article-title":"Drug Metabolism in Older People-Aa Key Consideration in Achieving Optimal Outcomes with Medicines","volume":"67","author":"Andrew","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1475-6773.2010.01156.x","article-title":"Performance Characteristics of a Methodology to Quantify Adverse Events over Time in Hospitalized Patients","volume":"46","author":"Paul","year":"2011","journal-title":"Health Serv. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The Influence of Sex on Pharmacokinetics","volume":"42","author":"Janice","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/PTS.0000000000000190","article-title":"Events in Korean Traditional Medicine Hospitals: A Retrospective Medical Record Review","volume":"14","author":"Jee-In","year":"2018","journal-title":"J. Patient Saf."},{"key":"B21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3892\/mco.2020.2174","article-title":"Survey of Serious Adverse Events and Safety Evaluation of Oral Anticancer Drug Treatment in Japan: A Retrospective Study","volume":"14","author":"Kenji","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4212\/cjhp.v67i6.1404","article-title":"Measuring Adverse Drug Events on Hospital Medicine Units with the Institute for Healthcare Improvement Trigger Tool: a Chart Review","volume":"67","author":"Lau","year":"2014","journal-title":"Can. J. Hosp. Pharm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1200\/JOP.2016.016634","article-title":"Performance of a Trigger Tool for Identifying Adverse Events in Oncology","volume":"13","author":"Lipitz-Snyderman","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1182\/bloodadvances.2021005800","article-title":"Establishment of a Predictive Model for GvHD-free, Relapse-free Survival after Allogeneic HSCT Using Ensemble Learning","volume":"6","author":"Makoto","year":"2021","journal-title":"Blood Adv."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1097\/PTS.0000000000000576","article-title":"Applying the Global Trigger Tool in German Hospitals:A Pilot in Surgery and Neurosurgery","volume":"16","author":"Mareen","year":"2019","journal-title":"J. Patient Saf."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.2147\/IJGM.S338389","article-title":"Risk Assessment of Pulmonary Metastasis for Cervical Cancer Patients by Ensemble Learning Models: A Large Population Based Real-World Study","volume":"14","author":"Menglin","year":"2021","journal-title":"Int. J. general Med."},{"key":"B27","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE).Version 5.0","year":"2017"},{"key":"B28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0897190013513302","article-title":"Adverse Drug Events in Critically Ill Patients with Cancer: Incidence, Characteristics, and Outcomes","volume":"27","author":"Nazer","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"B29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/bmjqs-2012-001219","article-title":"Assessment of the Global Trigger Tool to Measure, Monitor and Evaluate Patient Safety in Cancer Patients: Reliability Concerns Are Raised","volume":"22","author":"Otto","year":"2013","journal-title":"BMJ Qual. Saf."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaoncol.2015.3440","article-title":"Hospitalizations during Systemic Therapy for Metastatic Lung Cancer: A Systematic Review of Real World vs Clinical Trial Outcomes","volume":"1","author":"Prince","year":"2015","journal-title":"JAMA Oncol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232095","article-title":"Validating the Chinese Geriatric Trigger Tool and Analyzing Adverse Drug Event Associated Risk Factors in Elderly Chinese Patients: A Retrospective Review","volume":"15","author":"Qiaozhi","year":"2020","journal-title":"PLoS One."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e003034","DOI":"10.1136\/bmjopen-2013-003034","article-title":"A Pilot Study on Record Reviewing with A Priori Patient Selection","volume":"3","author":"Sezgin","year":"2013","journal-title":"BMJ Open."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.4037\/ajcc2011818","article-title":"Adverse Drug Events in Intensive Care Units: a Cross-Sectional Study of Prevalence and Risk Factors","volume":"20","author":"Simon","year":"2011","journal-title":"Am. J. Crit. Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/cam4.2812","article-title":"Developing a Cancer-specific Trigger Tool to Identify Treatment-Related Adverse Events Using Administrative Data","volume":"9","author":"Weingart","year":"2020","journal-title":"Cancer Med."},{"key":"B35","volume-title":"World Cancer Report: Cancer Research for Cancer Prevention","author":"Wild Cp","year":"2020"},{"key":"B36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/PTS.0000000000000329","article-title":"Adverse Events at Baseline in a Chinese General Hospital: A Pilot Study of the Global Trigger Tool","volume":"16","author":"Xiao-Di","year":"2016","journal-title":"Patient Saf."},{"key":"B37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21037\/tau-21-780","article-title":"Contrast between Traditional and Machine Learning Algorithms Based on a Urine Culture Predictive Model: a Multicenter Retrospective Study in Patients with Urinary Calculi","volume":"11","author":"Yuhui","year":"2022","journal-title":"Transl. Androl. urology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"659099","DOI":"10.3389\/fphar.2021.659099","article-title":"Predicting Adverse Drug Events in Chinese Pediatric Inpatients with the Associated Risk Factors: A Machine Learning Study","volume":"12","author":"Ze","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4103\/jcrt.JCRT_577_18","article-title":"Risk of Serious Adverse Event and Fatal Adverse Event with Molecular Target Anticancer Drugs in Cancer Patients: A Meta-Analysis","volume":"15","author":"Zhiwei","year":"2019","journal-title":"Cancer Res. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.896104\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T06:01:48Z","timestamp":1656482508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.896104\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":39,"alternative-id":["10.3389\/fphar.2022.896104"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.896104","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"article-number":"896104"}}